The electronic MEdical Records and GEnomics (eMERGE) network successfully generated and returned comprehensive risk profiles using logic and data specific to 11 conditions in a secure and semi-automated fashion employing a customized REDCap database.
Abstract
Abstract Objective To describe the development and implementation of an automated platform for genomic risk prediction that integrates multiple data types. Materials and methods Using the REDCap infrastructure, we constructed the R4 (Recruitment, Results, and Risk Reduction) platform to intake data from clinical sites, partner laboratories, participant surveys, and electronic health record (EHR) data across 13 institutions. Results The R4 Portal successfully integrated data to generate genome-informed risk assessments (GIRAs) across 11 conditions for a 23 840 person cohort. Testing phases and quality control led to network-wide protocols ensuring consistency and accuracy. Discussion As the science of estimating disease risk evolves, standardized and high-throughput methods of collecting and manipulating complex data are required. Platforms should be open-source, modular, and reusable, ensuring flexibility, security, and integration across healthcare environments. Conclusion The electronic MEdical Records and GEnomics (eMERGE) network successfully generated and returned comprehensive risk profiles using logic and data specific to 11 conditions in a secure and semi-automated fashion employing a customized REDCap database.
An integrated pipeline designed to address challenges in PRS calculation, risk stratification, and individual-level interpretation is presented, establishing a comprehensive toolbox for PRS analysis and enhancing reproducibility, transparency, and usability in both research and clinical contexts.
Pedro Victor Barbosa Araújo, Tayná da Silva Fiúza, J. Kroll et al.· bioRxiv· 0 citations
This study demonstrates the development and early multi-site implementation of a Research Electronic Data Capture–based framework for inborn errors of immunity that provides a scalable foundation for rare disease research and may support improved clinical decision-making.
M. Ahmed, A. A. Bousfiha, Farida Almarzooqi· Frontiers in Immunology· 0 citations
This Review highlights AI and ML frameworks for integrating genomic, multi-omics, and EHR data, and discusses how these approaches are reshaping genomics research as well as clinical practice.
Rasika Venkatesh, M. Ritchie· Nature reviews genetics· 0 citations
Background Phenotype-genotype associations underpin precision medicine by enabling disease prevention, early diagnosis, risk stratification, therapeutic target discovery, and personalized treatment. However, the rapid growth of scientific evidence has made manual curation of these associations increasingly labor-intens...
Caiwan Sun, Yi Xin, Sarah Zeng et al.· bioRxiv· 0 citations
This review explores current methods, technologies and governance structures for the sharing of genomic data, as well as national genome initiatives and the genomics industry to offer a broad overview and proposes four recommendations for future directions to improve the consistency, security and interoperability of da...
Ekta Maini, Dhairya Marwaha, Dheeraj Marwaha· ITM Web of Conferences· 0 citations
SYNDATA supports reproducible generation of ALS/eCRF-conformant datasets for operational validation, reporting development, and workflow testing before real trial data are available, but its demonstrated value is limited to the evaluated operational use case.
Szymon Musik, Jacek Zalewski, Julia Jurkowska et al.· Healthcare· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.